6 completed, 2 unknown, 1 not yet recruiting, 1 recruiting. 3 Not applicable, 3 Phase 4, 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 2, Not yet recruiting 1 |
| Phase 4 | 3 | Completed 1, Recruiting 1, Unknown 1 |
| Phase 3 | 2 | Terminated 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow policosanol: new trials by email Literature Review of policosanol trials Research Report on policosanol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Policosanol and Exercise on Fitness and Lipids in People With Elevated Blood Lipids Policosanol, Placebo, Concurrent Exercise Training - Dyslipidemia, Elevated Blood Lipids | Not applicable | Not yet recruiting | Mahidol University | 120 | 2026-06-22 | 2026-07-17 |
| Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia Choline fenofibrate, Policosanol - Dyslipidemia, Atherosclerosis | Phase 4 | Recruiting | Seoul National University Bundang Hospital | 56 | 2023-06-01 | 2026-05-05 |
| Efficacy and Safety Study of Policosanol policosanol, placebo - Endothelial Dysfunction | Phase 3 | Unknown | General Hospital of Chinese Armed Police Forces | 100 | 2015-06-01 | 2015-09-07 |
| Low-dose Statins and Nutraceuticals in High-intensity Statin-intolerant Patients Association low-dose statin and nutraceuticals - Coronary Artery Disease | Phase 4 | Unknown | University of Roma La Sapienza | 100 | 2013-11-01 | 2013-12-05 |
| Study of Policosanol to Improve Platelet Reactivity After Percutaneous Coronary Stent Implantation (PCI) high maintenance clopidogrel, routine dual antiplatelet, policosanol plus dual antiplatelet - Coronary Artery Disease | Phase 4 | Completed | Shenyang Northern Hospital | 350 | 2011-03-01 | 2015-12-16 |
| The Role of a Combination of Nutraceuticals in the Control of Cardiovascular Risk Armolipid Prev - Metabolic Syndrome | Completed | Federico II University | 150 | 2010-09-01 | 2016-02-03 | |
| Armolipid Plus and Metabolic Syndrome Armolipid Plus - Metabolic Syndrome | Not applicable | Completed | Rottapharm | 66 | 2009-09-01 | 2010-09-02 |
| Effects of Armolipid Plus on Cholesterol Levels and Endothelial Function Mixture of Berberine, Policosanol, Red Yeast, Placebo - Hyperlipidemia, Endothelial Dysfunction | Completed | Federico II University | 50 | 2007-07-01 | 2008-04-16 | |
| Effect of Policosanol as Monotherapy and Adjunctive to Statin Therapy Policosanol, Placebo, Policosanol Plus Already In Use Statin Therapy - High Cholesterol | Not applicable | Completed | James Backes, PharmD | 54 | 2007-07-01 | 2015-10-08 |
| Preliminary Study of Safety and Efficacy of Policosanol Policosanol, Placebo - Dyslipidemia, HIV Infections | Phase 2 | Completed | Rush University Medical Center | 54 | 2005-09-01 | 2013-07-26 |
| Cholesterol-Lowering Effects of Policosanol Policosanol - Hypercholesterolemia, Combined Hyperlipidemia | Phase 3 | Terminated | Drug Commission of the German Medical Association | 2000-09-01 | 2006-07-21 |
Dyslipidemias (3) · Coronary Artery Disease (2) · Hypercholesterolemia (2) · Metabolic Syndrome (2) · Atherosclerosis (1) · Diabetes Mellitus, Type 2 (1) · HIV Infections (1) · Hyperlipidemias (1)
Federico II University (2) · Drug Commission of the German Medical Association (1) · General Hospital of Chinese Armed Police Forces (1) · James Backes, PharmD (1) · Mahidol University (1) · Rottapharm (1) · Rush University Medical Center (1) · Seoul National University Bundang Hospital (1) · Shenyang Northern Hospital (1) · University of Roma La Sapienza (1)
Italy (4) · China (2) · United States (2) · South Korea (1) · Thailand (1)
Serafino Fazio, MD (2) · Barbara A Swanson, DNSc (1) · Bruno Trimarco, MD (1) · Heiner K. Berthold, MD, PhD (1) · James M. Backes, PharmD (1) · Yaling Han, MD (1)
PMID 16705107, PMID 17887938, PMID 19552735, PMID 19699071, PMID 20550469, PMID 22402933, PMID 22500237, PMID 24945081
R21AT003077 (1)